Submission for OMB Review, 38219-38220 [2011-16161]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 125 / Wednesday, June 29, 2011 / Notices
Actions Taken To Prevent Recurrence
no significant adverse health effect to
the patient is expected.
Actions Taken To Prevent Recurrence
Licensee—The licensee modified its
procedure to insert the needles that hold
the prostate in place prior to obtaining
the ultrasound images instead of
immediately before the seed needles are
inserted. In addition, the sagittal image
will be captured at the time of planning
image acquisition and confirmed
periodically throughout the case, and
the radiation oncologist will personally
confirm the location of the reference
base prior to dispensing the first seed.
State—The Louisiana Department of
Environmental Quality conducted an
investigation, reviewed the licensee’s
corrective actions, and found the
corrective actions to be adequate.
mstockstill on DSK4VPTVN1PROD with NOTICES
AS10–07 Medical Event at Mayo
Clinic in Rochester, Minnesota
Date and Place—March 23, 2010,
Rochester, Minnesota.
Nature and Probable Consequences—
The Mayo Clinic (the licensee) reported
a medical event associated with an HDR
biliary treatment for liver carcinoma
containing 329 GBq (8.9 Ci) of iridium192. A patient was prescribed to receive
four fractionated doses totaling 16 Gy
(1,600 rad) to the liver. The treatment to
the liver should have produced an
estimated dose to the duodenum (wrong
treatment site) of 1.2 Gy (120 rad) but
as a result of the event it received a dose
of about 10 Gy (1,000 rad). The patient
and referring physician were informed
of this event.
During the second fractioned
treatment, the measurement cable was
inserted into the catheter and it was
noted that it extended about 17 cm
beyond the programmed treatment
distance used during the first fractioned
treatment. It was concluded that the
measurement wire on the first treatment
had met with some resistance at a tight
bend and that it was not at the end of
the catheter. This resulted in overdosing
the duodenum (wrong treatment site).
Upon discovery of the treatment
distance error and overdose, the
licensee changed the written directive to
add a fifth fractioned treatment to
correct for the underdose of the liver. A
lesser total dose to the liver was given
because of concerns regarding the dose
already received by the duodenum. The
authorized user concluded that no
chronic health effect to the patient is
expected.
Cause(s)—The medical event was
caused by human error in failing to
verify that the correct catheter length
was entered into the HDR unit.
VerDate Mar<15>2010
17:48 Jun 28, 2011
Jkt 223001
38219
licensee’s corrective actions. The NRC
has retained the services of an
independent medical consultant to
determine if any significant health
effects to the patient are expected.
Licensee—The licensee committed to
taking several corrective actions
including the imaging of inserted
catheters prior to treatments and
performing catheter length checks prior
to HDR treatments.
State—On April 6, 2010, the
Minnesota Department of Health (MDH)
staff performed a reactive inspection of
the licensee’s HDR program. The MDH
approved the licensee’s corrective
actions and did not take enforcement
action.
Dated at Rockville, Maryland, this 23rd day
of June, 2011.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Acting Secretary of the Commission.
NRC10–08 Medical Event at
Providence Hospital in Novi, Michigan
OVERSEAS PRIVATE INVESTMENT
CORPORATION
Date and Place—August 30, 2010,
Novi, Michigan.
Nature and Probable Consequences—
Providence Hospital (the licensee)
reported that a medical event occurred
associated with an anal brachytherapy
treatment using 32 seeds containing
iodine-125. The intended dose was 90
Gy (9,000 rad) to the tumor. Instead, the
patient’s seminal vesicle received 19.79
Gy (1,979 rad) more than intended and
the bladder received 3.68 Gy (368 rad)
more than intended. The patient and
referring physician were informed of
this event.
On September 1, 2010, a follow-up CT
scan showed that the permanent
implants had been inserted about 4 cm
from the intended location. The licensee
reported that the tumor near the anus
and rectum received a maximum dose of
8 Gy (800 rad). The licensee calculated
the dose difference to the surrounding
tissue as a result of the improper
permanent implant placement. The
licensee concluded that no significant
adverse health effect to the patient is
expected.
Cause(s)—The licensee determined
that the cause of the event was that they
did not use tissue markers to confirm
source placement and the insertion
needle did not have a visible mark to
ensure proper depth placement.
[OMB–3420–0011; OPIC–115]
Actions Taken To Prevent Recurrence
Licensee—Procedures were modified
to administer sources as prescribed in
the written directive as follows: (1) Any
interstitial procedure that requires the
use of fluoroscopy alone will be done
with the use of tissue markers to
confirm source placement, and
(2) interstitial procedures that use
fluoroscopy alone will have needle
depth verified. The licensee completed
training of licensee staff on the event
and the corrective actions by October 1,
2010.
NRC—The NRC’s Region III staff
reviewed and concurred on the
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
[FR Doc. 2011–16266 Filed 6–28–11; 8:45 am]
BILLING CODE 7590–01–P
Submission for OMB Review
Overseas Private Investment
Corporation (OPIC).
ACTION: Request for approval.
AGENCY:
Under the provisions of the
Paperwork Reduction Act (44 U.S.C.
Chapter 35), agencies are required to
publish a Notice in the Federal Register
notifying the public that the agency has
prepared an information collection for
OMB review and approval. {Comments
were solicited in the 60 day notice,
posted on [October 2, 2007], and no
comments were received.}
DATES: This 30-day notice is to inform
the public, that this collection is being
submitted to OMB for approval.
ADDRESSES: Copies of the subject form
may be obtained from the Agency
submitting officer.
FOR FURTHER INFORMATION CONTACT:
OPIC Agency Submitting Officer: Essie
Bryant, Record Manager, Overseas
Private Investment Corporation, 1100
New York Avenue, NW., Washington,
DC 20527; (202) 336–8563.
SUMMARY:
Summary Form Under Review
Type of Request: Revised form.
Title: Application for Financing.
Form Number: OPIC–115.
Frequency of Use: Once per investor
per project.
Type of Respondents: Business or
other institution (except farms);
individuals.
Standard Industrial Classification
Codes: All.
Description of Affected Public: U.S.
companies or citizens investing
overseas.
Reporting Hours: 9 hours per project.
Number of Responses: 190 per year.
Federal Cost: $12,754.
Authority for Information Collection:
Sections 231, 234(a), 239(d), and 240A
of the Foreign Assistance Act of 1961,
as amended.
E:\FR\FM\29JNN1.SGM
29JNN1
38220
Federal Register / Vol. 76, No. 125 / Wednesday, June 29, 2011 / Notices
Abstract (Needs and Uses): The
application is the principal document
used by OPIC to determine the
soundness of the proposed project and
the applicant’s qualifications for
receiving OPIC financial assistance and
to assess the environmental impact and
developmental effects of the project, and
to measure the economic effects for the
U.S. and the host country’s economy.
Dated: June 23, 2011.
Nicole Cadiente,
Administrative Counsel, Department of Legal
Affairs.
Abstract (Needs and Uses): The
application is the document used by
OPIC to determine the investor’s and the
project’s eligibility for political risk
insurance when used in conjunction
with a completed application for OPIC
financing.
Dated: June 23, 2011.
Nicole Cadiente
Administrative Counsel, Department of Legal
Affairs.
BILLING CODE M
Dated: June 23, 2011.
Nicole Cadiente,
Administrative Counsel, Department of Legal
Affairs.
OVERSEAS PRIVATE INVESTMENT
CORPORATION
[FR Doc. 2011–16159 Filed 6–28–11; 8:45 am]
[FR Doc. 2011–16155 Filed 6–28–11; 8:45 am]
[FR Doc. 2011–16161 Filed 6–28–11; 8:45 am]
BILLING CODE M
Overseas Private Investment
Corporation (OPIC).
ACTION: Request for approval.
AGENCY:
Submission for OMB Review
Overseas Private Investment
Corporation (OPIC).
ACTION: Request for approval.
AGENCY:
Under the provisions of the
Paperwork Reduction Act (44 U.S.C.
chapter 35), agencies are required to
publish a Notice in the Federal Register
notifying the public that the agency has
prepared an information collection for
OMB review and approval.
DATES: This 30-day notice is to inform
the public, that this collection is being
submitted to OMB for approval.
ADDRESSES: Copies of the subject form
may be obtained from the Agency
submitting officer.
FOR FURTHER INFORMATION CONTACT:
OPIC Agency Submitting Officer: Essie
Bryant, Record Manager, Overseas
Private Investment Corporation, 1100
New York Avenue, NW., Washington,
DC 20527; (202) 336–8563.
mstockstill on DSK4VPTVN1PROD with NOTICES
Summary Form Under Review
Type of Request: New form.
Title: Short—Form Application for
Political Risk Insurance.
Form Number: OPIC–247.
Frequency of Use: Once per investor
per project.
Type of Respondents: Business or
other institution (except farms);
individuals.
Standard Industrial Classification
Codes: All.
Description of Affected Public: U.S.
companies or citizens investing
overseas.
Reporting Hours: 2 hours per project.
Number of Responses: 50 per year.
Federal Cost: $5,000.
Authority for Information Collection:
Sections 231, 234(a), 239(d), and 240A
of the Foreign Assistance Act of 1961,
as amended.
Jkt 223001
Under the provisions of the
Paperwork Reduction Act (44 U.S.C.
Chapter 35), agencies are required to
publish a Notice in the Federal Register
notifying the public that the agency has
prepared an information collection for
OMB review and approval.
DATES: This 30-day notice is to inform
the public, that this collection is being
submitted to OMB for approval.
ADDRESSES: Copies of the subject form
may be obtained from the Agency
submitting officer.
FOR FURTHER INFORMATION CONTACT:
OPIC Agency Submitting Officer: Essie
Bryant, Record Manager, Overseas
Private Investment Corporation, 1100
New York Avenue, NW., Washington,
DC 20527; (202) 336–8563.
SUMMARY:
SUMMARY:
17:48 Jun 28, 2011
BILLING CODE M
Submission for OMB Review
OVERSEAS PRIVATE INVESTMENT
CORPORATION
VerDate Mar<15>2010
Abstract (Needs and Uses): The
application is the principal document
used by OPIC to determine the
investor’s and the project’s eligibility for
political risk insurance, assess the
environmental impact and
developmental effects of the project,
measure the economic effects for the
U.S. and the host country economy, and
collect information for insurance
underwriting analysis.
Summary Form Under Review
Type of Request: Extension, without
change, of a currently approved
collection.
Title: Self-Monitoring Questionnaire
for Insurance and Finance Projects.
Form Number: OPIC 162.
Frequency of Use: One per investor
per project.
Type of Respondents: Business or
other institution (except farms);
individuals.
Standard Industrial Classification
Codes: All.
Description of Affected Public: U.S.
companies or citizens investing
overseas.
Reporting Hours: 4 hours per form.
Number of Responses: one per year.
Federal Cost: $0.
Authority for Information Collection:
Sections 231, 234(a), 239(d), and 240A
of the Foreign Assistance Act of 1961,
as amended.
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
OVERSEAS PRIVATE INVESTMENT
CORPORATION
Submission of OMB review; comments
request
Overseas Private Investment
Corporation (OPIC).
ACTION: Request for comments.
AGENCY:
Under the provisions of the
Paperwork Reduction Act (44 U.S.C.
Chapter 35), agencies are required to
publish a Notice in the Federal Register
notifying the public that the Agency has
prepared an information collection
request for OMB review and approval
and has requested public review and
comment on the submission. Comments
are being solicited on the need for the
information; the accuracy of the
Agency’s burden estimate; the quality,
practical utility and clarity of the
information to be collected; and on
ways to minimize the reporting burden,
including automated collection
techniques and uses of other forms of
technology. The proposed form under
review, OPIC form 241, is summarized
below.
DATES: Comments must be received
within 30 calendar-days of publication
of this Notice.
ADDRESSES: Copies of the subject form
and the request for review prepared for
submission to OMB may be obtained
from the Agency Submitting Officer.
Comments on the form should be
submitted to the Agency Submitting
Officer.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Agency Submitting Officer: Essie
Bryant, Records Management Officer,
Overseas Private Investment
Corporation, 1100 New York Avenue,
NW., Washington, DC 20527; (202) 336–
8563.
Summary of Form Under Review:
Type of Request: New Form.
E:\FR\FM\29JNN1.SGM
29JNN1
]]>Agencies
[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Pages 38219-38220]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16161]
=======================================================================
-----------------------------------------------------------------------
OVERSEAS PRIVATE INVESTMENT CORPORATION
[OMB-3420-0011; OPIC-115]
Submission for OMB Review
AGENCY: Overseas Private Investment Corporation (OPIC).
ACTION: Request for approval.
-----------------------------------------------------------------------
SUMMARY: Under the provisions of the Paperwork Reduction Act (44 U.S.C.
Chapter 35), agencies are required to publish a Notice in the Federal
Register notifying the public that the agency has prepared an
information collection for OMB review and approval. {Comments were
solicited in the 60 day notice, posted on [October 2, 2007], and no
comments were received.{time}
DATES: This 30-day notice is to inform the public, that this collection
is being submitted to OMB for approval.
ADDRESSES: Copies of the subject form may be obtained from the Agency
submitting officer.
FOR FURTHER INFORMATION CONTACT: OPIC Agency Submitting Officer: Essie
Bryant, Record Manager, Overseas Private Investment Corporation, 1100
New York Avenue, NW., Washington, DC 20527; (202) 336-8563.
Summary Form Under Review
Type of Request: Revised form.
Title: Application for Financing.
Form Number: OPIC-115.
Frequency of Use: Once per investor per project.
Type of Respondents: Business or other institution (except farms);
individuals.
Standard Industrial Classification Codes: All.
Description of Affected Public: U.S. companies or citizens
investing overseas.
Reporting Hours: 9 hours per project.
Number of Responses: 190 per year.
Federal Cost: $12,754.
Authority for Information Collection: Sections 231, 234(a), 239(d),
and 240A of the Foreign Assistance Act of 1961, as amended.
[[Page 38220]]
Abstract (Needs and Uses): The application is the principal
document used by OPIC to determine the soundness of the proposed
project and the applicant's qualifications for receiving OPIC financial
assistance and to assess the environmental impact and developmental
effects of the project, and to measure the economic effects for the
U.S. and the host country's economy.
Dated: June 23, 2011.
Nicole Cadiente,
Administrative Counsel, Department of Legal Affairs.
[FR Doc. 2011-16161 Filed 6-28-11; 8:45 am]
BILLING CODE M
